Loading...
ALUVI logo

UV Germi SAENXTPA:ALUVI Stock Report

Market Cap €8.8m
Share Price
n/a
1Y8.7%
7D0%
1D0%
Portfolio Value
​
View

UV Germi SA

ENXTPA:ALUVI Stock Report

Market Cap: €8.8m

UV Germi (ALUVI) Stock Overview

Designs, manufactures, and sells ultraviolet devices for the treatment of pollution control, disinfection and decontamination of water, air and surfaces in France. More details

ALUVI fundamental analysis
Snowflake Score
Valuation0/6
Future Growth0/6
Past Performance1/6
Financial Health5/6
Dividends0/6

Risk Analysis

Volatile share price over the past 3 months compared to the French market

Large one-off items impacting financial results

Profit margins (1.5%) are lower than last year (8.3%)

Does not have a meaningful market cap (€9M)


ALUVI Community Fair Values

Create Narrative

See what others think this stock is worth. Follow their fair value or set your own to get alerts.

NEW435,612 members

Join community and earn perks

Gain real feedbackFrom our editorial team, personally. Not silence.
Grow your followingReal investors. The kind who actually invest, not scroll past.
Unlock free accessFree premium subscription for consistent and quality authors.
Learn moreCreate Narrative
B
BlackGoat
R
RockeTeller
I
Investingwilly
D
davidlsander
435,612 investors already sharing narratives
View all narratives

UV Germi SA Competitors

Price History & Performance

Summary of share price highs, lows and changes for UV Germi
Historical stock prices
Current Share Price€2.75
52 Week High€3.07
52 Week Low€1.88
Beta0.28
1 Month Change1.85%
3 Month Change16.53%
1 Year Change8.70%
3 Year Change-48.31%
5 Year Change-69.27%
Change since IPO-50.72%

Recent News & Updates

Recent updates

Analysis Article • Oct 31

UV Germi's (EPA:ALUVI) Returns On Capital Are Heading Higher

To find a multi-bagger stock, what are the underlying trends we should look for in a business? Typically, we'll want to...
Analysis Article • Jul 10

Insufficient Growth At UV Germi SA (EPA:ALUVI) Hampers Share Price

When close to half the companies in France have price-to-earnings ratios (or "P/E's") above 17x, you may consider UV...
Analysis Article • Apr 14

We Like These Underlying Return On Capital Trends At UV Germi (EPA:ALUVI)

To find a multi-bagger stock, what are the underlying trends we should look for in a business? Amongst other things...
Analysis Article • Feb 15

UV Germi SA's (EPA:ALUVI) Popularity With Investors Is Under Threat From Overpricing

UV Germi SA's ( EPA:ALUVI ) price-to-earnings (or "P/E") ratio of 46.2x might make it look like a strong sell right now...
Analysis Article • Dec 13

UV Germi (EPA:ALUVI) Might Have The Makings Of A Multi-Bagger

If we want to find a potential multi-bagger, often there are underlying trends that can provide clues. Firstly, we'll...
Analysis Article • Aug 13

UV Germi SA's (EPA:ALUVI) Business Is Trailing The Market But Its Shares Aren't

When close to half the companies in France have price-to-earnings ratios (or "P/E's") below 14x, you may consider UV...
Analysis Article • Apr 25

We Like These Underlying Return On Capital Trends At UV Germi (EPA:ALUVI)

Finding a business that has the potential to grow substantially is not easy, but it is possible if we look at a few key...
Analysis Article • Oct 23

Here's Why I Think UV Germi (EPA:ALUVI) Might Deserve Your Attention Today

For beginners, it can seem like a good idea (and an exciting prospect) to buy a company that tells a good story to...
Analysis Article • Sep 07

Some Confidence Is Lacking In UV Germi SA's (EPA:ALUVI) P/E

When close to half the companies in France have price-to-earnings ratios (or "P/E's") below 21x, you may consider UV...

Shareholder Returns

ALUVIFR MachineryFR Market
7D0%1.5%-2.0%
1Y8.7%-22.1%-0.02%

Return vs Industry: ALUVI exceeded the French Machinery industry which returned -15.5% over the past year.

Return vs Market: ALUVI exceeded the French Market which returned 2% over the past year.

Price Volatility

Is ALUVI's price volatile compared to industry and market?
ALUVI volatility
ALUVI Average Weekly Movement6.6%
Machinery Industry Average Movement5.1%
Market Average Movement4.2%
10% most volatile stocks in FR Market9.5%
10% least volatile stocks in FR Market2.2%

Stable Share Price: ALUVI's share price has been volatile over the past 3 months compared to the French market.

Volatility Over Time: ALUVI's weekly volatility (7%) has been stable over the past year, but is still higher than 75% of French stocks.

About the Company

FoundedEmployeesCEOWebsite
200939Willy Fortunatowww.uvgermi.fr

UV Germi SA designs, manufactures, and sells ultraviolet devices for the treatment of pollution control, disinfection and decontamination of water, air and surfaces in France. The company offers its products in the areas of air range, surface range, drinking water range, seawater, dechloramination, drinking water private use, wastewater and industrial process water, private pool, legionella, germiserre, and industrial clean water range. The company was founded in 2009 and is headquartered in Saint-Viance, France.

UV Germi SA Fundamentals Summary

How do UV Germi's earnings and revenue compare to its market cap?
ALUVI fundamental statistics
Market cap€8.82m
Earnings (TTM)€101.31k
Revenue (TTM)€6.81m
87.0x
P/E Ratio
1.3x
P/S Ratio

Is ALUVI overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
ALUVI income statement (TTM)
Revenue€6.81m
Cost of Revenue€3.94m
Gross Profit€2.87m
Other Expenses€2.77m
Earnings€101.31k

Last Reported Earnings

Dec 31, 2025

Next Earnings Date

n/a

Earnings per share (EPS)0.032
Gross Margin42.12%
Net Profit Margin1.49%
Debt/Equity Ratio2.4%

How did ALUVI perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/09/09 09:38
End of Day Share Price 2026/09/09 00:00
Earnings2025/12/31
Annual Earnings2025/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

UV Germi SA is covered by 3 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Charles-Louis PlanadeTPICAP Midcap
Valerie Ducreux DieppeTPICAP Midcap
Christel ClemeTPICAP Midcap